Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Reparixin (Repertaxin) | CXCR1/2 Inhibitor | MedChemExpress
Reparixin (瑞帕利辛) – 美仑生物
Reparixin (Repertaxin) | ≥99%(HPLC) | Selleck | CXCR 拮抗剤
Reparixin | CXCR1/2 inhibitor | Probechem Biochemicals
Reparixin | C14H21NO3S | CID 9838712 - PubChem
Reparixin | CAS 266359-83-5 | SCBT - Santa Cruz Biotechnology
Reparixin - CXCR1/CXCR2 Receptor Inhibitor | APExBIO
Reparixin inhibits NOD1/2-induced tumorigenesis of CSCC cells by ...
Reparixin improves survival in critically ill and transplant patients ...
Treatment with Reparixin ameliorated PM-enhanced pulmonary fibrosis and ...
Reparixin L-lysine salt - CXCR1/CXCR2 Inhibitor | APExBIO
Effect of reparixin on ACPA-induced hypersensitivity. Mechanical ...
Impact of reparixin treatment on aberrant inflammatory responses in ...
The protective effects of reparixin against endothelial ischemia ...
Reparixin potentiates anti-neoplastic effects of chemoterapics on TC ...
(A) PWT of vincristine- and oxaliplatin-treated mice with reparixin ...
Reparixin effects on TC cells depend on both CXCR1 and CXCR2. (A ...
Reparixin – Application in Therapy and Current Clinical Research
Reparixin inhibits the epithelial-to-mesenchymal transition (EMT) in TC ...
Reparixin reduces TC SCs functional activities. (A) The sphere-forming ...
Reparixin reduces the levels of IL-1β in the brain after middle ...
Reparixin – Aplicación en terapia e investigaciones clínicas actuales
Phase Ib pilot study to evaluate reparixin in combination with weekly ...
Study on the Effectiveness and Safety of Reparixin for Adults with ...
Fenretinide, Tocilizumab & Reparixin Provide Multifaceted Disruption of ...
Therapeutic inhibition of CXCR2 by Reparixin attenuates acute lung ...
Effect of acute inhibition of CXCR1/2 by reparixin on behavioral ...
Reparixin decreases short-term (24 h) PMN infiltrate in the ischemic ...
Doses and modalities of administration of reparixin in the eight ...
Reparixin | 瑞帕利辛 | CXCR | TargetMol
Reparixin inhibits TC cell proliferation by decreasing DNA synthesis ...
| Reparixin restores in a concentration-dependent fashion the GATA1 ...
Reparixin reduces neutrophil activity in the brain after middle ...
Effect of reparixin on infarct volume 24 h after permanent MCAO in five ...
(PDF) Phase Ib pilot study to evaluate reparixin in combination with ...
The effect of reparixin on survival in patients at high risk for in ...
Mean total reparixin concentration versus time on day 1 (line with ...
Reparixin prevents motor impairment after middle cerebral artery ...
Reparixin Supplier | CAS 266359-83-5 | Focus Biomolecules
Phase Ib Pilot Study to Evaluate Reparixin in Combination with Weekly ...
Frontiers | The CXCR1/CXCR2 Inhibitor Reparixin Alters the Development ...
The CXCR1/CXCR2 Inhibitor Reparixin Alters the Development of ...
(PDF) Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted ...
Reparixin L-lysine salt | RayBiotech
Reparixin as a Potential Antiepileptogenic Agent: Modulation of the ...
(PDF) Peri‐operative Reparixin therapy resulted in 50% 5‐year insulin ...
| Reparixin reduces in a concentration-dependent fashion the frequency ...
| Reparixin decreased in a concentration-dependent fashion the degree ...
| Reparixin decreases in a concentration-dependent fashion the fibrosis ...
Reparixin (Repertaxin，瑞帕利辛) - 仅供科研 | CXCR1/2 抑制剂 | MCE
Reparixin (Repertaxin) | CXCR inhibitor | CAS 266359-83-5 | Selleck
(PDF) The effect of reparixin on survival in patients at high risk for ...
Reparixin L-lysine salt | Chemokine CXC Receptors | Tocris Bioscience
Reparixin Phase 3 trial in severe COVID-19 | Dompé U.S.
Reparixin lysine | C20H35N3O5S | CID 9932389 - PubChem
Multiple anti-tumor effects of Reparixin on thyroid cancer - PMC
Reparixin (Repertaxin; DF 1681Y) | CAS 266359-83-5 | AbMole BioScience ...
Reparixin L-lysine salt | CXCL8 receptor inhibitor | Buy from Supplier ...
Reparixin (Repertaxin)｜CAS 266359-83-5｜TCIJT｜製品詳細
Reparixin (Repertaxin) | CXCR 拮抗剂 | 现货供应 | 美国品牌 | 免费采购电话400-668-6834
Репариксин — формула
Targeting IL8 as a sequential therapy strategy to overcome chemotherapy ...
Interleukin-8 as a therapeutic target for chronic low back pain ...
A pilot study on reparixin, a CXCR1/2 antagonist, to assess safety and ...
A randomized, placebo-controlled phase 2 study of paclitaxel in ...
Reparixin, an Inhibitor of CXCR2 Function, Attenuates Inflammatory ...
A Multicenter Phase 2 Randomized Controlled Study on the Efficacy and ...
Reparixin, a CXCR1/2 inhibitor in islet allotransplantation - PMC
The CXCL1-CXCR2 Axis as a Component of Therapy Resistance, a Source of ...
Konform ar | Sigma-Aldrich
Recent advances in therapeutic strategies for triple-negative breast ...
Reparilexin ® - Riassunto delle caratteristiche
(PDF) Reparixin, an Inhibitor of CXCR2 Function, Attenuates ...
Inhibition of CXCR1/2 reduces the emperipolesis between neutrophils and ...
Frontiers | The role of gut microbiota imbalance in preeclampsia ...
Elucidating cancer-vascular paracrine signaling using a human ...
The role of gut microbiota imbalance in preeclampsia pathogenesis ...
